If a One Medical provider determines that GLP-1 treatment is not appropriate for you based on your medical evaluation - due to BMI thresholds, contraindications, or clinical judgment - One Medical providers can discuss alternative weight management approaches
Trends Endocrinol Metab 31:410421 Allison KC, Chao AM, Bruzas MB et al (2023) A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder
It means regular check-ins where we monitor how you are tolerating the medication, adjust dosing as needed, and talk openly about progress and any side effects
The diabetes titration schedule (SUSTAIN protocol) The SUSTAIN trial program (Sorli et al., Diabetes Care , 2017) used a faster titration schedule because the primary endpoint was glycemic control, not weight loss, and HbA1c responds faster than adipose tissue
Just watch for any stomach sensitivity, and dont overdo it